A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease.
Phase of Trial: Phase I/II
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Fampridine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
- 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.
- 24 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.